라메디텍

462510KOSDAQ의료용 기기 제조업

43.3 / 100

Reference Date: 2026-07-24

Financial Score6.0 / 40

News Sentiment21.3 / 25

Momentum6.0 / 20

Disclosure10.0 / 15

AI Analysis: the high debt ratio poses financial risk, ROE is below the industry average. Slightly down 2.4% over the past month, and news sentiment is positive.

Company InformationBased on 2025 Annual Report

Business Overview

Lameditech is a company specializing in developing laser-based skincare and medical devices, as well as laser blood collection systems. Its key products include the Puracel series, CareBeam, Rayvet, and Handly, with laser skincare devices accounting for approximately 91% of total revenue in 2025.

Number of Employees

68people

Average Salary

54.6M KRW

Score Calculation Basis

Detailed Financial Score

PER

—Industry Average 20.044.0Point

PBR

2.95Industry Average 1.140.0Point

2.6x industry avg (risky)

ROE

-82.45Industry Average 8.000.0Point

Well below industry avg

Debt Ratio

77.79Industry Average 11.650.0Point

6.7x industry avg (risky)

Trend 2024~20252.0 / 10 points

Revenue Growth Rate

2.0 / 3

Avg ▲9.3% (1-year basis)

Operating Profit Growth Rate

0.0 / 3

Avg ▼22.6% (1-year basis)

ROE Trend

0.0 / 4

Avg ROE -75.5% (declining, 2yr)

Detailed News Sentiment

4 totalPositive 4Neutral 0Negative 0Average Sentiment Score 85

Positive
라메디텍 "핸디레이 프로 활용 미숙아 채혈 임상 학술지 게재"
라메디텍의 레이저 채혈기 '핸디레이 프로'가 미숙아 임상에서 안전성과 유효성을 입증하며 긍정적인 연구 결과를 발표했다.
Positive
라메디텍, 신규 레이저 의료기기 ‘FX-7000M’ 식약처 허가 신청…...
라메디텍의 새로운 레이저 의료기기 FX-7000M의 식약처 허가 신청으로 스킨부스터 시장에서의 경쟁력 강화와 성장 가능성이 높아졌다.
Positive
라메디텍, 'FX-7000M' 의료기기 허가 신청 소식에 장중 8%↑...
라메디텍의 'FX-7000M' 의료기기 인허가 신청 소식으로 장중 주가가 크게 상승했다.

Detailed Momentum

52-week position1.0Point

Near 52w low (4%, downtrend)

Current 2,825Won52-week high 8,55052-week low 2,560

1-month return2.0Point

1m -2.42% (slight drop)

Volume trend3.0Point

Volume flat

Detailed Disclosure

0 totalPositive 0Neutral 0Negative 0